← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Biocorrx Pharmaceuticals Inc
Anaheim, CA
$7,405,564
Total funding
1
Grants
Funding over time
peak $4.1M · FY2024–25$5M$3.8M$2.5M$1.3M$0
'24
'25
Funding mix
By agency
NIH$7,405,564 · 1
By mechanism
U01$7,405,564 · 1
Investigators at Biocorrx Pharmaceuticals Inc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Efficacy, safety, and pharmacokinetic study of BICX104 naltrexone subcutaneous implant alone and in combination with bupropion for the treatment of Methamphetamine Use Disorder (MUD).$4,131,123
U01 · FY2024 · DA
Efficacy, safety, and pharmacokinetic study of BICX104 naltrexone subcutaneous implant alone and in combination with bupropion for the treatment of Methamphetamine Use Disorder (MUD).$3,274,441
U01 · FY2025 · DA